References
- Britt KL, Cuzick J, Phillips KA. Key steps for effective breast cancer prevention. Nat Rev Cancer. 2020;20(8):417–436.
- Farhadi P, Yarani R, Valipour E, et al. Cell line-directed breast cancer research based on glucose metabolism status. Biomed Pharmacother. 2022;146:112526.
- Vaupel P, Multhoff G. Revisiting the Warburg effect: historical dogma versus current understanding. J Physiol. 2021;599(6):1745–1757.
- Spencer NY, Stanton RC. The Warburg effect, lactate, and nearly a century of trying to cure cancer. Semin Nephrol. 2019;39(4):380–393.
- Tekade RK, Sun X. The Warburg effect and glucose-derived cancer theranostics. Drug Discov Today. 2017;22(11):1637–1653.
- Shulman RG, Rothman DL. The glycogen shunt maintains glycolytic homeostasis and the Warburg effect in cancer. Trends Cancer. 2017;3(11):761–767.
- Nava GM, Madrigal Perez LA. Metabolic profile of the Warburg effect as a tool for molecular prognosis and diagnosis of cancer. Expert Rev Mol Diagn. 2022;22(4):439–447.
- Lebelo MT, Joubert AM, Visagie MH. Warburg effect and its role in tumourigenesis. Arch Pharm Res. 2019;42(10):833–847.
- Unterlass JE, Curtin NJ. Warburg and Krebs and related effects in cancer. Expert Rev Mol Med. 2019;21:e4.
- Kozal K, Jóźwiak P, Krześlak A. Contemporary perspectives on the Warburg effect inhibition in cancer therapy. Cancer Control. 2021;28:10732748211041243.
- MA M. Ubiquitination: friend and foe in cancer. Int J Biochem Cell Biol. 2018;101:80–93.
- Sun T, Liu Z, Yang Q. The role of ubiquitination and deubiquitination in cancer metabolism. Mol Cancer. 2020;19(1):146.
- Deng L, Meng T, Chen L, et al. The role of ubiquitination in tumorigenesis and targeted drug discovery. Signal Transduct Target Ther. 2020;5(1):11.
- Zou T, Lin Z. The involvement of ubiquitination machinery in cell cycle regulation and cancer progression. Int J Mol Sci. 2021;22(11):5754.
- Hu X, Wang J, Chu M, et al. Emerging role of ubiquitination in the regulation of PD-1/PD-L1 in cancer immunotherapy. Mol Ther. 2021;29(3):908–919.
- Ryu H, Sun XX, Chen Y, et al. The deubiquitinase USP36 promotes snoRNP group SUMOylation and is essential for ribosome biogenesis. EMBO Rep. 2021;22(6):e50684.
- Yan Y, Xu Z, Huang J, et al. The deubiquitinase USP36 Regulates DNA replication stress and confers therapeutic resistance through PrimPol stabilization. Nucleic Acids Res. 2020;48(22):12711–12726.
- Liu K, Li F, Han H, et al. Parkin regulates the activity of pyruvate kinase M2. Biol Chem. 2016;291(19):10307–10317.
- Zhang D, Xu X, Ye Q. Metabolism and immunity in breast cancer. Front Med. 2021;15(2):178–207.
- Hill M, Tran N. miRNA interplay: mechanisms and consequences in cancer. Dis Model Mech. 2021;14(4):dmm047662.
- Zhang Z, Deng X, Liu Y, et al. PKM2, function and expression and regulation. Cell Biosci. 2019;9(1):52.
- He X, Du S, Lei T, et al. PKM2 in carcinogenesis and oncotherapy. Oncotarget. 2017;8(66):110656–110670.
- DeVine T, Sears RC, Dai MS. The ubiquitin-specific protease USP36 is a conserved histone H2B deubiquitinase. Biochem Biophys Res Commun. 2018;495(3):2363–2368.
- Vaupel P, Schmidberger H, Mayer A. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression. Int J Radiat Biol. 2019;95(7):912–919.
- Chen M, Liu H, Li Z, et al. Mechanism of PKM2 affecting cancer immunity and metabolism in tumor microenvironment. J Cancer. 2021;12(12):3566–3574.
- Wiese EK, Hitosugi T. Tyrosine kinase signaling in cancer metabolism: pKM2 paradox in the Warburg effect. Front Cell Dev Biol. 2018;6:79.
- Zam W, Ahmed I, Yousef H. The Warburg effect on cancer cells survival: the role of sugar starvation in cancer therapy. Curr Rev Clin Exp Pharmacol. 2021;16(1):30–38.
- van Niekerk G, Engelbrecht AM. Role of PKM2 in directing the metabolic fate of glucose in cancer: a potential therapeutic target. Cell Oncol (Dordr). 2018;41(4):343–351.
- Yu P, Li AX, Chen XS, et al. PKM2-c-Myc-Survivin cascade regulates the cell proliferation, migration, and tamoxifen resistance in breast cancer. Front Pharmacol. 2020;11:550469.
- Zhang W, Zhang X, Huang S, et al. FOXM1D potentiates PKM2-mediated tumor glycolysis and angiogenesis. Mol Oncol. 2021;15(5):1466–1485.
- Sun Z, Shi K, Yang S, et al. Effect of exosomal miRNA on cancer biology and clinical applications. Mol Cancer. 2018;17(1):147.
- Petri BJ, Klinge CM. Regulation of breast cancer metastasis signaling by miRnas. Cancer Metastasis Rev. 2020;39(3):837–886.
- Ali Syeda Z, Langden SSS, Munkhzul C, et al. Regulatory mechanism of MicroRNA expression in cancer. Int J Mol Sci. 2020;21(5):1723.
- He B, Zhao Z, Cai Q, et al. miRNA-based biomarkers, therapies, and resistance in cancer. Int J Biol Sci. 2020;16(14):2628–2647.
- Hen J, Cai S, Gu T, et al. MiR-140-3p Impedes gastric cancer progression and metastasis by regulating BCL2/BECN1-mediated autophagy. Onco Targets Ther. 2021;14:2879–2892.
- Dou D, Ren X, Han M, et al. Circ_0008039 supports breast cancer cell proliferation, migration, invasion, and glycolysis by regulating the miR-140-3p/ska2 axis. Mol Oncol. 2021;15(2):697–709.